It was interesting that NAP1L1 affected the proliferation of pancreatic neuroendocrine tumor cells via modulation of p57 (Kip2) promoter methylation, whether affected insulin secretion or regulated blood glucose, however, the mechanism had not been elucidated [30]. The gene discussed is NAP1L1; the disease is pancreatic neuroendocrine tumor.